vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and RADIANT LOGISTICS, INC (RLGT). Click either name above to swap in a different company.
RADIANT LOGISTICS, INC is the larger business by last-quarter revenue ($232.1M vs $168.4M, roughly 1.4× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -12.3%). Over the past eight quarters, RADIANT LOGISTICS, INC's revenue compounded faster (12.1% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Radiant Logistics, Inc. is a leading third-party logistics provider offering end-to-end supply chain solutions, domestic and international freight forwarding, warehousing, and last-mile delivery services. It primarily serves North American markets, with key client segments including retail, manufacturing, e-commerce, and industrial sectors, helping businesses optimize logistics workflows and cut operational costs.
ESPR vs RLGT — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $232.1M |
| Net Profit | — | $5.3M |
| Gross Margin | — | — |
| Operating Margin | 50.6% | 3.2% |
| Net Margin | — | 2.3% |
| Revenue YoY | 143.7% | -12.3% |
| Net Profit YoY | — | -18.0% |
| EPS (diluted) | $0.32 | $0.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $232.1M | ||
| Q3 25 | $87.3M | $226.7M | ||
| Q2 25 | $82.4M | $220.6M | ||
| Q1 25 | $65.0M | $214.0M | ||
| Q4 24 | $69.1M | $264.5M | ||
| Q3 24 | $51.6M | $203.6M | ||
| Q2 24 | $73.8M | $206.0M | ||
| Q1 24 | $137.7M | $184.6M |
| Q4 25 | — | $5.3M | ||
| Q3 25 | $-31.3M | $1.3M | ||
| Q2 25 | $-12.7M | $4.9M | ||
| Q1 25 | $-40.5M | $2.5M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | $-29.5M | $3.4M | ||
| Q2 24 | $-61.9M | $4.8M | ||
| Q1 24 | $61.0M | $-703.0K |
| Q4 25 | 50.6% | 3.2% | ||
| Q3 25 | -11.4% | 0.9% | ||
| Q2 25 | 8.6% | 2.4% | ||
| Q1 25 | -34.0% | 1.6% | ||
| Q4 24 | -6.4% | 3.3% | ||
| Q3 24 | -31.0% | 1.9% | ||
| Q2 24 | 3.5% | 2.4% | ||
| Q1 24 | 52.5% | -0.5% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | -35.9% | 0.6% | ||
| Q2 25 | -15.4% | 2.2% | ||
| Q1 25 | -62.2% | 1.2% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | -57.2% | 1.7% | ||
| Q2 24 | -83.9% | 2.3% | ||
| Q1 24 | 44.3% | -0.4% |
| Q4 25 | $0.32 | $0.11 | ||
| Q3 25 | $-0.16 | $0.03 | ||
| Q2 25 | $-0.06 | $0.10 | ||
| Q1 25 | $-0.21 | $0.05 | ||
| Q4 24 | $-0.14 | $0.13 | ||
| Q3 24 | $-0.15 | $0.07 | ||
| Q2 24 | $-0.33 | $0.11 | ||
| Q1 24 | $0.34 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $31.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $229.8M |
| Total Assets | $465.9M | $439.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $31.9M | ||
| Q3 25 | $92.4M | $28.1M | ||
| Q2 25 | $86.1M | $22.9M | ||
| Q1 25 | $114.6M | $19.0M | ||
| Q4 24 | $144.8M | $19.9M | ||
| Q3 24 | $144.7M | $10.4M | ||
| Q2 24 | $189.3M | $24.9M | ||
| Q1 24 | $226.6M | $31.2M |
| Q4 25 | $-302.0M | $229.8M | ||
| Q3 25 | $-451.4M | $225.7M | ||
| Q2 25 | $-433.5M | $226.0M | ||
| Q1 25 | $-426.2M | $218.2M | ||
| Q4 24 | $-388.7M | $214.4M | ||
| Q3 24 | $-370.2M | $212.4M | ||
| Q2 24 | $-344.2M | $209.4M | ||
| Q1 24 | $-294.3M | $206.0M |
| Q4 25 | $465.9M | $439.4M | ||
| Q3 25 | $364.0M | $445.3M | ||
| Q2 25 | $347.1M | $426.8M | ||
| Q1 25 | $324.0M | $414.5M | ||
| Q4 24 | $343.8M | $386.8M | ||
| Q3 24 | $314.1M | $375.3M | ||
| Q2 24 | $352.3M | $371.2M | ||
| Q1 24 | $373.1M | $364.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $12.4M |
| Free Cash FlowOCF − Capex | — | $11.6M |
| FCF MarginFCF / Revenue | — | 5.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 2.33× |
| TTM Free Cash FlowTrailing 4 quarters | — | $8.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $12.4M | ||
| Q3 25 | $-4.3M | $2.5M | ||
| Q2 25 | $-31.4M | $3.1M | ||
| Q1 25 | $-22.6M | $-5.7M | ||
| Q4 24 | $-35.0M | $15.7M | ||
| Q3 24 | $-35.3M | $205.0K | ||
| Q2 24 | $-7.2M | $1.3M | ||
| Q1 24 | $53.8M | $3.9M |
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $977.0K | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | — | $-6.4M | ||
| Q4 24 | — | $14.1M | ||
| Q3 24 | $-35.5M | $-1.9M | ||
| Q2 24 | $-7.3M | $-185.0K | ||
| Q1 24 | $53.8M | $1.8M |
| Q4 25 | — | 5.0% | ||
| Q3 25 | — | 0.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | -3.0% | ||
| Q4 24 | — | 5.3% | ||
| Q3 24 | -68.7% | -0.9% | ||
| Q2 24 | -9.9% | -0.1% | ||
| Q1 24 | 39.0% | 1.0% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.0% | 0.3% | ||
| Q4 24 | 0.0% | 0.6% | ||
| Q3 24 | 0.3% | 1.0% | ||
| Q2 24 | 0.1% | 0.7% | ||
| Q1 24 | 0.1% | 1.2% |
| Q4 25 | — | 2.33× | ||
| Q3 25 | — | 1.90× | ||
| Q2 25 | — | 0.63× | ||
| Q1 25 | — | -2.26× | ||
| Q4 24 | — | 2.43× | ||
| Q3 24 | — | 0.06× | ||
| Q2 24 | — | 0.26× | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
RLGT
| Transferred Over Time | $201.2M | 87% |
| Other | $25.0M | 11% |
| Value Added Services | $4.2M | 2% |
| Transferred At Point In Time | $1.8M | 1% |
